Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure

W. A. Rees, S. Kwiatkowski, Scott D Stanley, D. E. Granstrom, J. M. Yang, C. G. Gairola, D. Drake, J. Glowczyk, W. E. Woods, T. Tobin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

trans-3-Hydroxycotinine is the major urinary metabolite of nicotine in man and can serve as an important biomarker of tobacco smoke exposure. A sensitive ELISA test for trans-3-hydroxycotinine was developed with an 1-50 for this nicotine biomarker of between 1.0-3.0 ng/ml. This ELISA test has about 10 fold less affinity for cotinine and 1000-fold less affinity for nicotine and other nicotine metabolites. No matrix effects were detectable in human saliva and relatively small matrix effects (I-50 for trans-3-hydroxycotinine, about 25 ng/ml) in urine was observed. The assay readily detected levels of apparent trans-3-hydroxycotinine in urine samples from smoke-exposed mice and rats. This ELISA is therefore a sensitive test for the determination of trans-3-hydroxycotinine in plasma, saliva, and urine samples from humans and animals, and can be used to monitor exposure to tobacco smoke or nicotine.

Original languageEnglish (US)
Title of host publicationASTM Special Technical Publication
PublisherAmerican Society for Testing and Materials
Pages149-162
Number of pages14
Volume1306
StatePublished - 1996
Externally publishedYes

Fingerprint

Nicotine
Biomarkers
Smoke
Tobacco
Metabolites
Rats
Assays
Animals
Plasmas

Keywords

  • Cotinine
  • Enzyme-Linked Immunosorbant Assay
  • Metabolite
  • Nicotine
  • t-3-hydroxycotinine

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Rees, W. A., Kwiatkowski, S., Stanley, S. D., Granstrom, D. E., Yang, J. M., Gairola, C. G., ... Tobin, T. (1996). Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. In ASTM Special Technical Publication (Vol. 1306, pp. 149-162). American Society for Testing and Materials.

Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. / Rees, W. A.; Kwiatkowski, S.; Stanley, Scott D; Granstrom, D. E.; Yang, J. M.; Gairola, C. G.; Drake, D.; Glowczyk, J.; Woods, W. E.; Tobin, T.

ASTM Special Technical Publication. Vol. 1306 American Society for Testing and Materials, 1996. p. 149-162.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rees, WA, Kwiatkowski, S, Stanley, SD, Granstrom, DE, Yang, JM, Gairola, CG, Drake, D, Glowczyk, J, Woods, WE & Tobin, T 1996, Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. in ASTM Special Technical Publication. vol. 1306, American Society for Testing and Materials, pp. 149-162.
Rees WA, Kwiatkowski S, Stanley SD, Granstrom DE, Yang JM, Gairola CG et al. Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. In ASTM Special Technical Publication. Vol. 1306. American Society for Testing and Materials. 1996. p. 149-162
Rees, W. A. ; Kwiatkowski, S. ; Stanley, Scott D ; Granstrom, D. E. ; Yang, J. M. ; Gairola, C. G. ; Drake, D. ; Glowczyk, J. ; Woods, W. E. ; Tobin, T. / Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. ASTM Special Technical Publication. Vol. 1306 American Society for Testing and Materials, 1996. pp. 149-162
@inbook{3b4774a00d74427994234093fee71c15,
title = "Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure",
abstract = "trans-3-Hydroxycotinine is the major urinary metabolite of nicotine in man and can serve as an important biomarker of tobacco smoke exposure. A sensitive ELISA test for trans-3-hydroxycotinine was developed with an 1-50 for this nicotine biomarker of between 1.0-3.0 ng/ml. This ELISA test has about 10 fold less affinity for cotinine and 1000-fold less affinity for nicotine and other nicotine metabolites. No matrix effects were detectable in human saliva and relatively small matrix effects (I-50 for trans-3-hydroxycotinine, about 25 ng/ml) in urine was observed. The assay readily detected levels of apparent trans-3-hydroxycotinine in urine samples from smoke-exposed mice and rats. This ELISA is therefore a sensitive test for the determination of trans-3-hydroxycotinine in plasma, saliva, and urine samples from humans and animals, and can be used to monitor exposure to tobacco smoke or nicotine.",
keywords = "Cotinine, Enzyme-Linked Immunosorbant Assay, Metabolite, Nicotine, t-3-hydroxycotinine",
author = "Rees, {W. A.} and S. Kwiatkowski and Stanley, {Scott D} and Granstrom, {D. E.} and Yang, {J. M.} and Gairola, {C. G.} and D. Drake and J. Glowczyk and Woods, {W. E.} and T. Tobin",
year = "1996",
language = "English (US)",
volume = "1306",
pages = "149--162",
booktitle = "ASTM Special Technical Publication",
publisher = "American Society for Testing and Materials",

}

TY - CHAP

T1 - Development and characterization of an ELISA for trans-3-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure

AU - Rees, W. A.

AU - Kwiatkowski, S.

AU - Stanley, Scott D

AU - Granstrom, D. E.

AU - Yang, J. M.

AU - Gairola, C. G.

AU - Drake, D.

AU - Glowczyk, J.

AU - Woods, W. E.

AU - Tobin, T.

PY - 1996

Y1 - 1996

N2 - trans-3-Hydroxycotinine is the major urinary metabolite of nicotine in man and can serve as an important biomarker of tobacco smoke exposure. A sensitive ELISA test for trans-3-hydroxycotinine was developed with an 1-50 for this nicotine biomarker of between 1.0-3.0 ng/ml. This ELISA test has about 10 fold less affinity for cotinine and 1000-fold less affinity for nicotine and other nicotine metabolites. No matrix effects were detectable in human saliva and relatively small matrix effects (I-50 for trans-3-hydroxycotinine, about 25 ng/ml) in urine was observed. The assay readily detected levels of apparent trans-3-hydroxycotinine in urine samples from smoke-exposed mice and rats. This ELISA is therefore a sensitive test for the determination of trans-3-hydroxycotinine in plasma, saliva, and urine samples from humans and animals, and can be used to monitor exposure to tobacco smoke or nicotine.

AB - trans-3-Hydroxycotinine is the major urinary metabolite of nicotine in man and can serve as an important biomarker of tobacco smoke exposure. A sensitive ELISA test for trans-3-hydroxycotinine was developed with an 1-50 for this nicotine biomarker of between 1.0-3.0 ng/ml. This ELISA test has about 10 fold less affinity for cotinine and 1000-fold less affinity for nicotine and other nicotine metabolites. No matrix effects were detectable in human saliva and relatively small matrix effects (I-50 for trans-3-hydroxycotinine, about 25 ng/ml) in urine was observed. The assay readily detected levels of apparent trans-3-hydroxycotinine in urine samples from smoke-exposed mice and rats. This ELISA is therefore a sensitive test for the determination of trans-3-hydroxycotinine in plasma, saliva, and urine samples from humans and animals, and can be used to monitor exposure to tobacco smoke or nicotine.

KW - Cotinine

KW - Enzyme-Linked Immunosorbant Assay

KW - Metabolite

KW - Nicotine

KW - t-3-hydroxycotinine

UR - http://www.scopus.com/inward/record.url?scp=5544252755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5544252755&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:5544252755

VL - 1306

SP - 149

EP - 162

BT - ASTM Special Technical Publication

PB - American Society for Testing and Materials

ER -